In addition, a supra-additive effect of SU in combination with high concentrations of intravenous gastric inhibitory polypeptide (GIP) has also been shown in HNF1A maturity-onset diabetes of the young (9) and in T2DM treated with standard dose glipizide (10). This evidence concerns the gene HNF1A and type 2 diabetes mellitus.